4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001567619-21-005396
Options or other derivatives
- President and CEO acquired 600,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
McCarthy Sean A. · President and CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-26 | Grant or award : show line 1 in the form Stock Option (right to buy) | +400,000 | 400,000 | D |
| 2021-02-27 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +200,000 | 200,000 | D |
Loading xslF345X03/doc1.xml…